SA
BNTX logo
BioNTech SE(BNTX)
Closing price · checked 11:58 AM ETAbout this dataData status
$80.96▼-0.42 (-0.52%)
Extended:$80.92-0.04 (-0.06%)· 11:58 AM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

BioNTech SE (BNTX)

R&D to Revenue

73.34%

Fiscal year · Period ending:

BNTX logo

BNTX R&D to Revenue

Latest reported73.34%
BNTX FY R&D/Revenue (0.00% → 73.34%)
Powered by
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

BNTX r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

BioNTech SE R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
73.344%−8.59 pts
81.9381%+35.25 pts
46.6902%+38.25 pts
8.4394%+3.42 pts
5.0212%−128.71 pts
133.7333%−74.82 pts
208.5534%+96.43 pts
112.1223%−26.67 pts
138.7967%+138.80 pts
0%—

Frequently asked questions: BNTX r&d to revenue

What is BioNTech SE (BNTX)'s current r&d to revenue?

BioNTech SE (BNTX)'s latest reported r&d to revenue (Fiscal year) is 73.34% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for BNTX?

Stock Alarm Pro provides 10 dated annual fiscal periods observations for BioNTech SE (BNTX)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare BNTX's r&d to revenue to peers or set an alert?

You can open BNTX's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on BNTX delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.